How tumors evade immunotherapy: DDB1 sends PD-L1 into nuclei, driving anti-PD-1 resistance
Immune checkpoint blockade has reshaped modern oncology, but its success remains uneven. Drugs that disrupt the PD-1/PD-L1 pathway can produce ...
Immune checkpoint blockade has reshaped modern oncology, but its success remains uneven. Drugs that disrupt the PD-1/PD-L1 pathway can produce ...
In a groundbreaking study published in the British Journal of Cancer, researchers have illuminated the complex and detrimental impact of ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine